184 related articles for article (PubMed ID: 29018054)
1. The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative.
Cohen K; Abadi U; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
Endocr Relat Cancer; 2018 Jan; 25(1):21-34. PubMed ID: 29018054
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the thyroid hormones-αvβ3 pathway in primary myeloma bone marrow cells and to bortezomib action.
Cohen K; Ellis M; Shinderman E; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
Leuk Lymphoma; 2015 Apr; 56(4):1107-14. PubMed ID: 25058375
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells.
Cohen K; Flint N; Shalev S; Erez D; Baharal T; Davis PJ; Hercbergs A; Ellis M; Ashur-Fabian O
Oncotarget; 2014 Aug; 5(15):6312-22. PubMed ID: 25071016
[TBL] [Abstract][Full Text] [Related]
4. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
Cohen K; Ellis M; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
Mol Cancer Res; 2011 Oct; 9(10):1385-94. PubMed ID: 21821675
[TBL] [Abstract][Full Text] [Related]
7. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
8. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer.
Shinderman-Maman E; Cohen K; Moskovich D; Hercbergs A; Werner H; Davis PJ; Ellis M; Ashur-Fabian O
Sci Rep; 2017 Nov; 7(1):16475. PubMed ID: 29184090
[TBL] [Abstract][Full Text] [Related]
10. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormones differentially regulate phosphorylation of ERK and Akt via integrin αvβ3 receptor in undifferentiated and differentiated PC-12 cells.
Barbakadze T; Natsvlishvili N; Mikeladze D
Cell Biochem Funct; 2014 Apr; 32(3):282-6. PubMed ID: 24214887
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone and anti-apoptosis in tumor cells.
Lin HY; Glinsky GV; Mousa SA; Davis PJ
Oncotarget; 2015 Jun; 6(17):14735-43. PubMed ID: 26041883
[TBL] [Abstract][Full Text] [Related]
13. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
16. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
17. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
[TBL] [Abstract][Full Text] [Related]
18. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
19. L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Lin HY; Sun M; Tang HY; Lin C; Luidens MK; Mousa SA; Incerpi S; Drusano GL; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2009 May; 296(5):C980-91. PubMed ID: 19158403
[TBL] [Abstract][Full Text] [Related]
20. Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac).
Leith JT; Hercbergs A; Kenney S; Mousa SA; Davis PJ
Endocr Res; 2018 Nov; 43(4):215-219. PubMed ID: 29611723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
